2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Infection
Concurrent

Multidrug-Resistant Infections: Is the Solution Drugs or Sewage?

Tuesday, March 24, 2026
8:00 AM - 8:45 AM Central Time
Location: W187

    Concurrent Session Moderator(s)

  • Tina Palmieri, MCCM

    Shriners Hospitals for Children Northern California, California

    Disclosure(s): No relevant financial relationship(s) to disclose.

The creep toward a post-antibiotic era due to antibiotic resistance has necessitated novel therapies for infection management in the ICU. This session will discuss 1) antibiotics for multidrug-resistant and extensively drug-resistant infections, considering novel drug mechanisms, delivery techniques, and combinations; 2) phage and nonantibiotic therapies, including how they work and their place in therapy, and 3) patient and family experience of surviving a multidrug-resistant organism treated with phage therapy.

Learning Objectives:

  • Identify novel drugs and techniques for multidrug-resistant (MDR) and extensively drug-resistant infections (XDR) infections
  • Explain the role of phage therapy in MDR and XDR infections
  • Consider the patient perspective on surviving MDR or XDR infections

Presentations:

  • 8:05 AM - 8:20 AM Central Time
    Change It, Slow It, Combine It: Antibiotics in MDR/XDR

    Kirstin Kooda, BCIDP, FCCM – Mayo Clinic Rochester

  • 8:20 AM - 8:35 AM Central Time
    Sewage Heroes: Bacteriophages for Refractory Infections

    John C. O'Horo, 157159 (he/him/his) – Mayo Clinic